FierceBiotech1h
FDA elevates Philips recall of hospital, home ventilator software
The FDA is getting the word out on a mandatory software update from Philips for its Trilogy line of portable life support ...
FierceBiotech5h
Big pharma, biotech relations ‘won't necessarily be symbiotic’ in future AI landscape: S&P
Big Pharma is investing heavily in AI to slash development timelines and foster innovation. | Big Pharma is investing heavily ...
FierceBiotech7h
Frazier Life Sciences adds $630M to 'evergreen' fund for small and mid-cap biotechs
Frazier Life Sciences has sourced a further $630 million for its fund focused on small and mid-cap biotechs. | Frazier Life ...
FierceBiotech7h
Nasal spray neutralizes army of respiratory diseases and protects mice from deadly influenza
The COVID-19 pandemic made the public acutely aware of how vulnerable their noses are. | The COVID-19 pandemic made us ...
FierceBiotech7h
Lundbeck taps Charles River for AI-enabled neuro drug discovery
Lundbeck has tapped Charles River Laboratories’ artificial intelligence capabilities to aid the discovery of neuroscience ...
FierceBiotech8h
Zephyrm rides IPO updraft toward Hong Kong listing, seeking cash for phase 3 cell therapy trials
Zephyrm Bioscience is gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO to bankroll phase 3 trials of its ...
FierceBiotech9h
Triveni ropes in $115M series B less than a year after $92M fundraise
Triveni Bio has roped in $115 million in series B funds to advance preclinical antibody programs designed to treat ...
FierceBiotech5h
Synchron’s brain-computer interface clears year-long safety study
Synchron has reported that its miniature brain-computer interface implant, threaded up through the blood vessels to help read the activity of the motor cortex, showed no major side effects in a ...